Supernus Wins Ban On Generic Seizure Treatment
By Adam Lidgett ( January 31, 2024, 7:11 PM EST) -- A New Jersey federal judge has handed a win to Supernus Pharmaceuticals Inc. in its bid to bar a competitor from being able to market a generic version of a seizure drug called Trokendi XR for the time being....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.